Can-Fite BioPharma Secures $4 Million via Repriced Warrant Exercise to Fund Clinical Pipeline
at www.tipranks.com (Thu, 5-Mar 7:47 AM)
Market Chameleon (Wed, 4-Mar 7:31 AM)
Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study
at www.benzinga.com (Wed, 4-Mar 10:07 AM)
Can-Fite’s Namodenoson Clears Phase 2a Safety Bar in Advanced Pancreatic Cancer
at www.tipranks.com (Wed, 4-Mar 7:33 AM)
Can-Fite BioPharma Adjourns Special Shareholders’ Meeting to March 10, 2026
at www.tipranks.com (Tue, 3-Mar 7:38 PM)
Can-Fite Secures Brazilian Patent for Sexual Dysfunction Therapy, Expanding LatAm Opportunities
Market Chameleon (Fri, 26-Dec 10:28 AM)
